Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Prepaid Assets (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Prepaid Assets for 2 consecutive years, with $26954.0 as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 45.94% to $26954.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26954.0 through Dec 2025, up 45.94% year-over-year, with the annual reading at $740193.0 for FY2025, N/A changed from the prior year.
  • Prepaid Assets for Q4 2025 was $26954.0 at Neuphoria Therapeutics, down from $222319.0 in the prior quarter.
  • The five-year high for Prepaid Assets was $740193.0 in Q2 2025, with the low at $18469.0 in Q4 2024.